The 20 Best Hodgkin Lymphoma Doctors Near Me in Silver Spring, MD

Bruce Cheson is an Oncologist in Washington, Washington, D.c.. Dr. Cheson is rated as an Elite provider by MediFind in the treatment of Hodgkin Lymphoma. His top areas of expertise are Follicular Lymphoma, Chronic B-Cell Leukemia (CBCL), Chronic Lymphocytic Leukemia (CLL), Non-Hodgkin Lymphoma, and Bone Marrow Transplant.

Catherine Bollard is a Pediatrics provider in Washington, Washington, D.c.. Dr. Bollard is rated as a Distinguished provider by MediFind in the treatment of Hodgkin Lymphoma. Her top areas of expertise are Hodgkin Lymphoma, Graft Versus Host Disease (GvHD), Leukemia, Acute Lymphoblastic Leukemia (ALL), and Bone Marrow Transplant.

Sanjal Desai is a Hematologist in Washington, Washington, D.c.. Dr. Desai is rated as a Distinguished provider by MediFind in the treatment of Hodgkin Lymphoma. Her top areas of expertise are Hodgkin Lymphoma, Classical Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Bone Marrow Transplant, and Bone Marrow Aspiration.

Robert Chen is a primary care provider, practicing in Family Medicine in Potomac, Maryland. Dr. Chen is rated as an Elite provider by MediFind in the treatment of Hodgkin Lymphoma. His top areas of expertise are Hodgkin Lymphoma, Mantle Cell Lymphoma (MCL), Non-Hodgkin Lymphoma, and Classical Hodgkin Lymphoma.

Dr. Frederick P. Smith is a medical oncologist specializing in breast cancer at Sibley Memorial Hospital and an instructor at Johns Hopkins School of Medicine and Georgetown University School of Medicine. He has a private practice in Washington, D.C. He is affiliated with Sibley Memorial Hospital and Suburban Hospital. Dr. Smith earned his medical degree from Saint Louis University School of Medicine. He completed a residency in internal medicine at Georgetown University Hospital, followed by a fellowship in oncology. Dr. Smith was named a 2012 Top Doctor in the Washington, D.C., Baltimore and Washington-Baltimore areas by Castle Connolly, as well as a Top MD by Consumers’ Checkbook Magazine. Prior to joining Johns Hopkins, Dr. Smith was the director of extramural oncology research at Georgetown University. In this position, he contributed over 50 articles to peer-reviewed medical journals. Dr. Smith is an integral advocate in the community for promoting access to clinical research. He has also contributed to clinical trials. Dr. Smith is rated as an Experienced provider by MediFind in the treatment of Hodgkin Lymphoma. His top areas of expertise are Breast Cancer, Paget Disease of the Breast, Virilizing Ovarian Tumor, and Ovarian Carcinosarcoma.

Wyndham Wilson is an Oncologist in Bethesda, Maryland. Dr. Wilson is rated as an Advanced provider by MediFind in the treatment of Hodgkin Lymphoma. His top areas of expertise are B-Cell Lymphoma, Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), and Burkitt Lymphoma.

Kieron Dunleavy is a Hematologist in Washington, Washington, D.c.. Dr. Dunleavy is rated as a Distinguished provider by MediFind in the treatment of Hodgkin Lymphoma. His top areas of expertise are Primary Mediastinal B-Cell Lymphoma (PMBCL), Non-Hodgkin Lymphoma, B-Cell Lymphoma, Burkitt Lymphoma, and Bone Marrow Aspiration.

Mary Mcmaster is an Internal Medicine provider in Bethesda, Maryland. Dr. Mcmaster is rated as an Advanced provider by MediFind in the treatment of Hodgkin Lymphoma. Her top areas of expertise are Chordoma, Hodgkin Lymphoma, Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), and Bone Marrow Aspiration.

Vera Malkovska is an Oncologist in Washington, Washington, D.c.. Dr. Malkovska is rated as an Advanced provider by MediFind in the treatment of Hodgkin Lymphoma. Her top areas of expertise are Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma, Sickle Cell Disease, and Bone Marrow Aspiration.

James Goedert is a primary care provider, practicing in Oncologist in Washington, Washington, D.c.. Dr. Goedert is rated as an Experienced provider by MediFind in the treatment of Hodgkin Lymphoma. His top areas of expertise are Burkitt Lymphoma, B-Cell Lymphoma, HIV/AIDS, Kaposi Sarcoma, and Colonoscopy.

Khaled M. El-Shami, M.B.Ch.B., Ph.D., is a medical oncologist at Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital, as well as an assistant professor of oncology in the Division of Hematologic Malignancies at Johns Hopkins University School of Medicine. Listen to Dr. El-Shami's Cancer Matters podcast episode to learn more about his work. Dr. El-Shami's clinical interests are in hematologic malignancies, including leukemias, lymphomas and myelomas.. Dr. El-Shami graduated from Alexandria University Faculty of Medicine in Alexandria, Egypt, where he did a residency in the Department of Neurosurgery. He was a Chevening Scholar as a M.S. student in molecular genetics at the University of Sussex in the United Kingdom, as well as a Sam Cohen Windhoek Scholar as a Ph.D. student in cancer immunology at the Weizmann Institute in Israel. Dr. El-Shami also completed a residency in internal medicine at George Washington University School of Medicine, a fellowship in tumor immunology and biology at the National Cancer Institute, and a fellowship in medical oncology at Johns Hopkins University School of Medicine. Dr. El-Shami previously served as faculty at Georgetown University and George Washington University. Dr. El-Shami has been named a Top Doctor by Washingtonian Magazine for several years. Dr. El-Shami is a member of the American Association for Advancement of Science, the American Association of Cancer Research, the American Association of Immunologists, the American Society for Gene Therapy and the American Society of Clinical Oncology. Dr. El-Shami's research focus is on hematologic malignancies, including acute and chronic leukemias, myelodysplastic syndromes, myeloprolifetive neplasms and lymphomas. He has received the National Institutes of Health Clinical Research Scholars Award, an American Medical Association Seed Grant and an American Society of Clinical Oncology Merit Award. Dr. El is rated as an Experienced provider by MediFind in the treatment of Hodgkin Lymphoma. His top areas of expertise are Large-Cell Immunoblastic Lymphoma, Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Acute Myeloblastic Leukemia without Maturation, and Bone Marrow Aspiration.

Bruce R. Kressel, M.D., is a medical oncologist at Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital and an instructor at Johns Hopkins University School of Medicine. In addition to an expertise in breast and lung cancer, Dr. Kressel has an expertise in gynecologic oncology and general medical oncology, with specific focuses on hematologic malignancies including lymphoma, leukemia and myeloma. Dr. Kressel earned his medical degree at Tufts University School of Medicine. He completed a residency in internal medicine at George Washington University School of Medicine, followed by a fellowship in hematology and oncology, also at George Washington University School of Medicine. Dr. Kressel completed a fellowship in oncology at the Georgetown Lombardi Comprehensive Cancer Center as well. Dr. Kressel has been regularly named one of America’s Top Doctors and one of America's Top Doctors for Cancer by Castle Connolly. He has also been named a Top Doctor in the Washington D.C. and Washington-Baltimore areas by Castle Connolly, as well as a Top Doctor by Consumers’ Checkbook Magazine and Washingtonian Magazine. Dr. Kressel is a member of the American Society of Clinical Oncology and the American Society of Hematology. Dr. Kressel has contributed to numerous publications, presentations and clinical trials. Dr. Kressel is rated as an Experienced provider by MediFind in the treatment of Hodgkin Lymphoma. His top areas of expertise are Essential Thrombocythemia, Non-Hodgkin Lymphoma, Gastric Lymphoma, Chronic Lymphocytic Leukemia (CLL), and Splenectomy.

"Dr. Rachit Kumar is a radiation oncologist specializing in genitourinary and gastrointestinal cancers. He is dedicated to patient-centered care, finding the most effective outcome for each patient and using the latest advances to minimize treatment time and side-effects. Dr. Kumar is frequently published in peer-reviewed journals on new methods of radiation therapy and the benefits to patient outcomes. He is a member of the Johns Hopkins Kimmel Cancer Center and treats patients at both Sibley Memorial Hospital and Suburban Hospital. Selected Publications Kumar R, Tchelebi LT, Anker CJ, Sharma N, Bianchi NA, Dragovic J, Goodman KA, Herman JM, Jiang Y, Jones WE, Kenney TJ, Lee P, Kundranda MK, Russo S, Small W, Suh WW, Yee N, and Jabbour SK. “American Radium Society (ARS) Appropriateness Use Criteria (AUC) for Loco-Regional Gastric Adenocarcinoma: Systemic Review and Guidelines.” American Journal of Clinical Oncology. 2022 Sep 1;45(9):391-402. Rooney MK, Traube B, Khan MK, Kumar R, and Walker GV. “Factors associated with image guided radiation therapy image rejection in a multi-site institution.” JCO Oncology Practice. Tang C, Hoffman KE, Allen PK, Gabel M, Schreiber D, Choi S, Chapin BF, Nguyen QN, Davis JW, Frank SJ, Navai N, McGuire SE, Anscher M, Pisters L, Pettaway CA, Kumar R, Linson P, Tripuraneni P, Tomaszewski JJ, Patel AB, Augspurger M, and Kuban DA. “Contemporary Prostate Cancer Treatment Choices in Multidisciplinary Clinics Referenced to National Trends.” Cancer. Tang C, Lei X, Smith GL, Pan HY, Hoffman K, Kumar R, Chapin BF, Shih YC, Frank SJ, and Smith BD. ""Influence of Geography on Prostate Cancer Treatment Coice: An Analysis of the National Medicare Database."" International Journal of Radiation Oncology Biology Physics. Tang C, Sherry AD, Haymaker C, Bathala T, Liu S, Fellman B, Aparicio A, Zurita-Saavedra A, Chun S, Reddy J, Choi S, Ghia A, McGuire S, Efstathiou E, Wang J, Wang J, Tu SM, Pilie P, Kovitz C, Kumar R, Roberts T, Borghero Y, Shi Z, Chapin B, Gomez D, Wistuba I, Corn and PG. “Addition of local consolidative therapy to intermittent hormone therapy for oligometastatic prostate cancer (EXTEND): a multicenter randomized phase II basket trial.” JAMA Oncology.". Dr. Kumar is rated as an Experienced provider by MediFind in the treatment of Hodgkin Lymphoma. His top areas of expertise are Pancreatic Cancer, Familial Pancreatic Cancer, Pancreatoblastoma, and Prostate Cancer.

Dr. Ralph V. Boccia is a hematologist affiliated with Sibley Memorial Hospital, Suburban Hospital, Shady Grove Adventist Hospital, Holy Cross Hospital and MedStar Georgetown University Hospital, where he is a clinical associate professor of medicine for the University, as well as the medical director of the International Oncology Network (ION) Clinical Research Program and the chairman of ION’s Medical Advisory Panel. He practices out of the Center for Cancer and Blood Disorders, of which he is the founder and medical director, located in Bethesda, Maryland and Germantown, Maryland. Dr. Boccia earned his medical degree from the Autonomous University of Guadalajara School of Medicine. He completed a residency in internal medicine at Kern Medical Center, followed by a fellowship in hematology, oncology and bone marrow transplant at the combined UCLA-Veterans Administration Program and The National Cancer Institute at the National Institutes of Health. Dr. Boccia is a member of the American College of Physicians, the American Society of Clinical Oncology, the American Society of Hematology and the American Society for Blood and Marrow Transplantation. Dr. Boccia has been listed as a Top Doctor by Washingtonian Magazine and Consumers’ Checkbook Magazine since 1992. He has also been recognized as a Super Doctor by The Washington Post Magazine and a Regional Top Doctor for Washington, D.C., Baltimore and Washington-Baltimore by Castle Connolly. Dr. Boccia has contributed to various articles with his research, published in journals such as Annals of Internal Medicine, Journal of Clinical Oncology and The Lancet. Recent News Articles and Media Coverage Bladder cancer trends in Montgomery and Prince George's counties: Welcome news - and 3 facts you need to know. NJ.com (08/16/2016) RCCA Expands to Maryland to Become One of the Nation's First Multi-State Oncology/Hematology Physician-Owned and -Operated Networks. OncLive (10/06/2015). Dr. Boccia is rated as an Advanced provider by MediFind in the treatment of Hodgkin Lymphoma. His top areas of expertise are Anemia, Multiple Myeloma, Thrombocytopenia, Adult Immune Thrombocytopenia, and Splenectomy.

Shana Jacobs is a Palliative Medicine provider in Silver Spring, Maryland. Dr. Jacobs is rated as an Experienced provider by MediFind in the treatment of Hodgkin Lymphoma. Her top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Leukemia, Osteosarcoma, Malignant Peripheral Nerve Sheath Tumor, and Bone Marrow Transplant.

Daya Sharma is an Oncologist in Silver Spring, Maryland. Dr. Sharma is rated as an Experienced provider by MediFind in the treatment of Hodgkin Lymphoma. His top areas of expertise are Astrocytoma, Embryonal Tumor with Multilayered Rosettes, Gliosarcoma, and Neuroepithelioma.

Sharon Savage is a Hematologist and an Oncologist in Bethesda, Maryland. Dr. Savage is rated as an Experienced provider by MediFind in the treatment of Hodgkin Lymphoma. Her top areas of expertise are Dyskeratosis Congenita, Aplastic Anemia, Aase Syndrome, Bone Marrow Transplant, and Hormone Replacement Therapy (HRT).

Charles Rabkin is a primary care provider, practicing in Internal Medicine in Bethesda, Maryland. Dr. Rabkin is rated as an Experienced provider by MediFind in the treatment of Hodgkin Lymphoma. His top areas of expertise are Stomach Cancer, Helicobacter Pylori Infection, Gastritis, Pernicious Anemia, and Hormone Replacement Therapy (HRT).

David Rogers is a primary care provider, practicing in Internal Medicine in Chevy Chase, Maryland. Dr. Rogers is rated as an Experienced provider by MediFind in the treatment of Hodgkin Lymphoma. His top areas of expertise are Rabson-Mendenhall Syndrome, High Cholesterol, Glucocorticoid-Remediable Aldosteronism, and Hypertension.

Harminder Sethi is an Oncologist in Hyattsville, Maryland. Dr. Sethi is rated as an Experienced provider by MediFind in the treatment of Hodgkin Lymphoma. His top areas of expertise are Angiosarcoma, Breast Cancer, Paget Disease of the Breast, and Anemia.